Literature DB >> 1790414

Bisphosphonates and vertebral fracture: an epidemiological perspective.

C Cooper, I Fogelman, L J Melton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1790414     DOI： 10.1007/bf01627071

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  20 in total

Review 1.  Use of bisphosphonates in the prevention of bone loss and fractures.

Authors:  A M Parfitt
Journal:  Am J Med       Date:  1991-11-25       Impact factor: 4.965

2.  The sickness impact profile: conceptual formulation and methodology for the development of a health status measure.

Authors:  M Bergner; R A Bobbitt; S Kressel; W E Pollard; B S Gilson; J R Morris
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

3.  Prevention of postmenopausal bone loss by tiludronate.

Authors:  J Y Reginster; M P Lecart; R Deroisy; N Sarlet; D Denis; D Ethgen; J Collette; P Franchimont
Journal:  Lancet       Date:  1989 Dec 23-30       Impact factor: 79.321

4.  Epidemiology of vertebral fractures in women.

Authors:  L J Melton; S H Kan; M A Frye; H W Wahner; W M O'Fallon; B L Riggs
Journal:  Am J Epidemiol       Date:  1989-05       Impact factor: 4.897

5.  Measuring health status: a new tool for clinicians and epidemiologists.

Authors:  S M Hunt; J McEwen; S P McKenna
Journal:  J R Coll Gen Pract       Date:  1985-04

6.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

Authors:  B L Riggs; S F Hodgson; W M O'Fallon; E Y Chao; H W Wahner; J M Muhs; S L Cedel; L J Melton
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

7.  Quantitative computed tomography assessment of spinal trabecular bone. II. In osteoporotic women with and without vertebral fractures.

Authors:  H Firooznia; C Golimbu; M Rafii; M S Schwartz; E R Alterman
Journal:  J Comput Tomogr       Date:  1984-04

8.  Quantitative computed tomography for prediction of vertebral fracture risk.

Authors:  C E Cann; H K Genant; F O Kolb; B Ettinger
Journal:  Bone       Date:  1985       Impact factor: 4.398

9.  Rising incidence of fracture of the proximal femur.

Authors:  W J Boyce; M P Vessey
Journal:  Lancet       Date:  1985-01-19       Impact factor: 79.321

10.  An examination of the association between vertebral deformities, physical disabilities and psychosocial problems.

Authors:  B Ettinger; J E Block; R Smith; S R Cummings; S T Harris; H K Genant
Journal:  Maturitas       Date:  1988-12       Impact factor: 4.342
View more
  3 in total

1.  Health-related quality of life in osteoporosis clinical trials. The Osteoporosis Quality of Life Study Group.

Authors:  G A Greendale; S L Silverman; R D Hays; C Cooper; T Spector; D Kiel; D B Reuben
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

2.  Combination of intermittent cyclical etidronate and hormone replacement therapy for postmenopausal non-responders to estrogen.

Authors:  M Nozaki; K Koera; R Egami; H Nagata; H Nakano
Journal:  Clin Drug Investig       Date:  2002       Impact factor: 2.859

3.  TOMOGRAFIC AND TENSIOMETRIC ASSESSMENT ON FEMURS FROM OOPHORECTOMIZED RATS SUBJECTED TO HORMONE REPLACEMENT THERAPY.

Authors:  Fábio Alexandre Martynetz; Maria de Lourdes Pessole Biondo-Simões; Juliano Rodrigo Martynetz; Tatiana Daher Martynetz; Elise Zimerman; Heraldo Mello Neto
Journal:  Rev Bras Ortop       Date:  2015-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.